Botox and Dermal Fillers were still my top treatments in 2024! So what is new in the clinic for 2025? It is predicted that the most popular aesthetic treatments will be. Regenerative aesthetics such as Sculptra.
Regenerative aesthetics
Regenerative medicine was one of our 2024 trend predictions, and it will continue to dominate in 2025, emphasising treatments that stimulate the body’s natural healing processes while extending beyond traditional injectables. Treatments like polynucleotides, bio-stimulating injectables, and exosomes surged in popularity in 2024 – trends that have paved the way for collagen banking and long term rejuvenation.
Focus on Collagen and Elastin
Patients are increasingly opting for regenerative treatments that focus on collagen and elastin production, offering natural results, which feeds into one of the other top aesthetic trends for 2025.
We are now looking to more natural treatments to harness our own bodies abilities to produce collagen, elastin, and hyaluronic acid” through methods like biostimulant injections and energy-based devices.
Watch out for:
- Stem cell therapies: Leveraging fat-derived stem cells for natural volume restoration
- Collagen banking: The concept of collagen banking involves using treatments, skincare products, and lifestyle habits early in life to “bank” or build up collagen reserves, slowing down its depletion and minimising the visible effects of ageing
- Exosomes: The global exosome market was valued at $140.7 million in 2023 and is anticipated to grow at a CAGR of 28.38% from 2024 to 2030. Look out for plant-based exosome treatments that promote elastin and hyaluronic acid production without the controversy of human-derived sources
- PRP: Cellenis® (distributed in the UK by AMP) is launching the first fully autologous regenerative volumiser. Cellenis® DermaFiller is an autologous, biological filler providing extended release of platelet-derived growth factors using the slow reabsorption properties of plasmatic proteins
Safety and Regulation updates
Regulation will also be a crucial piece of the puzzle here. While the Government was not forthcoming with its response to the consultation on the Licensing scheme for non-surgical cosmetic procedures in 2024, the industry is hopeful this will move forward in 2025.
The aesthetics industry anticipates greater government action on licensing cosmetic procedures to improve safety as well as a push towards legitimising the medical nature of aesthetic treatments, something that both The British Association of Medical Aesthetic Nurses (BAMAN) and British College of Aesthetic Medicine (BCAM) have championed.
The recognition of the sector by the Royal Society of Medicine (RSM) as a speciality was a significant move towards the medicalisation of aesthetics in 2024.
The creation of the RSM Section of Aesthetic Medicine and Surgery (SAMAS) significantly enhanced the credibility and medical standing of the field, signalling a growing acceptance of aesthetics within the wider medical community, often seen to have not considered it “real medicine”.
Aesthetics and CCR highlighted this trend in its recently published report, noting that “50% of private dentists in the UK have expanded their service offerings to include aesthetic treatments” and that a “comparable number of ophthalmology providers are also offering some form of aesthetic treatment (47%) with this trend being reflected in Optical Expresses acquisition of Harley Medical Group and sk:n Clinics.”
The report continues: “As more dental and ophthalmology clinics begin to offer aesthetic services, the market is becoming increasingly diverse, with more points of entry for patients seeking treatment. This diversification helps to destigmatise aesthetic procedures, aligning them more closely with the kind of expert care patients expect from medical professionals.
“In turn, this expansion will likely contribute to greater patient trust and confidence in the safety, effectiveness and professionalisation of aesthetic treatments. Ultimately, this shift suggests a future where aesthetics is seen as an integral part of healthcare, further solidifying its place in a wider medical landscape.”
